30 May 2018 – Scientific Advisory Board
Wednesday May 30, 2018
Wednesday May 30, 2018
Destiny Pharma has today announced theĀ formation of a new Scientific Advisory Board (SAB) to provide expert, independent analysis of the Company’s research and clinical development plans and to help in developing clinical strategies for its unique XF Platform.
Further details of the SAB can be found here.